Ten Doctors on FDA Panel Reviewing Abbott Heart Device Had Financial Ties With Company
Most of the doctors the FDA tapped to advise it on an Abbott medical device had financial ties to the company. The FDA didn鈥檛 disclose the payments.
Drugs
161 - 180 of 1,305 Results
-
-
Biden Is Right About $35 Insulin Cap but Exaggerates Prior Costs for Medicare Enrollees
Most Medicare enrollees likely were not paying a monthly average of $400 鈥 as President Joe Biden stated 鈥 before the insulin cap took effect. However, because costs and other factors result in widely varying prices, some Medicare enrollees might have paid that much in a given month.
The Supreme Court and the Abortion Pill
Episode 340The Supreme Court this week heard its first abortion case since overturning Roe v. Wade in 2022, about an appeals court ruling that would dramatically restrict the availability of the abortion pill mifepristone. But while it seems likely that this case could be dismissed on a technicality, abortion opponents have more challenges in the pipeline. Meanwhile, health issues are heating up on the campaign trail, as Republicans continue to take aim at Medicare, Medicaid, and the Affordable Care Act 鈥 all things Democrats are delighted to defend. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Lauren Weber of The Washington Post join 吃瓜不打烊 chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews 吃瓜不打烊鈥 Tony Leys, who wrote a 吃瓜不打烊-NPR 鈥淏ill of the Month鈥 feature about Medicare and a very expensive air-ambulance ride. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.
-
-
At Stake in Mifepristone Case: Abortion, FDA鈥檚 Authority, and Return to 1873 Obscenity Law
The end goal for a conservative Christian group鈥檚 mifepristone case before the Supreme Court: a de facto nationwide abortion ban.
By Sarah Varney -
A Paramedic Was Skeptical About This Rx for Stopping Repeat Opioid Overdoses. Then He Saw It Help.
For years, addiction response teams have traveled around Florida to connect people who have overdosed with resources and recovery centers. Now, a handful have a new tool in their kit: buprenorphine, which can help prevent the cravings and withdrawal symptoms that lead to more drug use.
-
Journalists Track Efforts to Curb the Opioid Crisis and Put Catholic Hospitals Under the Scope
吃瓜不打烊 and California Healthline staff made the rounds on national and local media in recent weeks to discuss their stories. Here鈥檚 a collection of their appearances.
The ACA Turns 14
Episode 339Saturday marks the 14th anniversary of the still somewhat embattled Affordable Care Act. Health and Human Services Secretary Xavier Becerra joins host Julie Rovner to discuss the accomplishments of the health law 鈥 and the challenges it still faces. Also this week, Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Mary Agnes Carey of 吃瓜不打烊 join Rovner to discuss what should be the final funding bill for HHS for fiscal 2024, next week鈥檚 Supreme Court oral arguments in a case challenging abortion medication, and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.
-
吃瓜不打烊 & PolitiFact HealthCheck
Biden Said Medicare Drug Price Negotiations Cut the Deficit by $160B. That’s Years Away.
Savings estimated by the Congressional Budget Office from allowing the federal government to negotiate Medicare drug prices are based on a 10-year cumulative projection.
-
-
Watch: Many Americans Are Unaware of HIV Prevention Medication
Some Americans mistakenly believe medication to prevent HIV transmission through sex is just for certain groups such as gay men, but anyone who鈥檚 at risk for contracting HIV through sex could benefit.
-
When Copay Assistance Backfires on Patients
Drugmakers offer copay assistance programs to patients, but insurers are tapping into those funds, not counting the amounts toward patient deductibles. That leads to unexpected charges. But the practice is under growing scrutiny.
Maybe It鈥檚 a Health Care Election After All
Episode 338Health care wasn鈥檛 expected to be a major theme for this year鈥檚 elections. But as President Joe Biden and former President Donald Trump secured their respective party nominations this week, the future of both Medicare and the Affordable Care Act appears to be up for debate. Meanwhile, the cyberattack of the UnitedHealth Group subsidiary Change Healthcare continues to do damage to the companies鈥 finances with no quick end in sight. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News, and Joanne Kenen of Johns Hopkins University and Politico Magazine join 吃瓜不打烊鈥 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Kelly Henning of Bloomberg Philanthropies about a new, four-part documentary series on the history of public health, 鈥淭he Invisible Shield.鈥 Plus, for 鈥渆xtra credit鈥 the panelists suggest health policy stories they read this week that they think you should read, too.
-
A New $16,000 Postpartum Depression Drug Is Here. How Will Insurers Handle It?
A pill form of an effective drug for postpartum depression hit the market in December, but most insurers do not yet have a policy on when or whether they will pay for it. The hurdles to obtain its predecessor medication have advocates worried.
-
-
Why Covid Patients Who Could Most Benefit From Paxlovid Still Aren鈥檛 Getting It
Price worries, bureaucratic obstacles, and 鈥淚鈥檓-over-covid-itis鈥 slow uptake of a drug that鈥檚 complicated to take but often effective.
By Arthur Allen The State of the Union Is … Busy
Episode 337At last, Congress is getting half of its annual spending bills across the finish line, albeit five months after the start of the fiscal year. Meanwhile, President Joe Biden delivers his annual State of the Union address, an over-the-counter birth control pill is (finally) available, and controversy erupts over new public health guidelines for covid-19 isolation. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join 吃瓜不打烊鈥 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Neera Tanden, the White House domestic policy adviser, about Biden鈥檚 health agenda. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week that they think you should read, too.
-
Biden Is Right. The US Generally Pays Double That of Other Countries for Rx Drugs.
Research has consistently found that, overall, U.S. prescription drug prices are significantly higher, sometimes two to four times as high, compared with prices in other high-income industrialized countries. However, some market factors can obscure actual prices, making comparisons harder.
-
America Worries About Health Costs 鈥 And Voters Want to Hear From Biden and Republicans
The presidential election is likely to turn on the simple question of whether Americans want Donald Trump back in the White House. But health care tops the list of household financial worries for adults from both parties.
By Julie Appleby and Phil Galewitz -
Journalists Examine Medicaid Unwinding, Farmworkers’ Mental Health, and the Big Opioid Payback
吃瓜不打烊 and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.